1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        MEA Prostate Cancer Nuclear Medicine Diagnostics Market – By Type

1.3.2        MEA Prostate Cancer Nuclear Medicine Diagnostics Market – By PET Product

1.3.3        MEA Prostate Cancer Nuclear Medicine Diagnostics Market – By End User

1.3.4        MEA Prostate Cancer Nuclear Medicine Diagnostics Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           MEA Prostate Cancer Nuclear Medicine Diagnostics Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        MEA PEST Analysis

4.3         Experts Opinion

5.           MEA Prostate Cancer Nuclear Medicine Diagnostics Market– Key Market Dynamics

5.1         Market Drivers

5.1.1        Surging Prevalence of Prostate Cancer

5.1.2        Soaring Demand for Early and Precise Diagnosis of Prostate Cancer

5.2         Market Restraints

5.2.1        Overpriced Related to the Prostate Cancer Diagnostics and Treatment

5.3         Market Opportunities

5.3.1        Expanding Use of Radiopharmaceuticals in Prostate Cancer

5.4         Future Trends

5.4.1        Developing Research Activities for Development of Innovative Imaging Agents

5.5         Impact Analysis

6.           Prostate Cancer Nuclear Medicine Diagnostics Market– MEA Analysis

6.1         MEA Prostate Cancer Nuclear Medicine Diagnostics Market Revenue Forecast and Analysis

7.           MEA Prostate Cancer Nuclear Medicine Diagnostics Market Analysis – By Type

7.1         Overview

7.2         MEA Prostate Cancer Nuclear Medicine Diagnostics Market, By Type, 2022 & 2028 (%)

7.3         SPECT

7.3.1        Overview

7.3.2        SPECT: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.4         PET

7.4.1        Overview

7.4.2        PET: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

8.           MEA Prostate Cancer Nuclear Medicine Diagnostics Market Analysis – By PET Product

8.1         Overview

8.2         MEA Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product, 2022 & 2028 (%)

8.3         F-18

8.3.1        Overview

8.3.2        F-18: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4         C-11

8.4.1        Overview

8.4.2        C-11: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.5         GA 68 PSMA

8.5.1        Overview

8.5.2        GA 68 PSMA: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.           MEA Prostate Cancer Nuclear Medicine Diagnostics Market – By End User

9.1         Overview

9.2         MEA Prostate Cancer Nuclear Medicine Diagnostics Market Share by End User- 2022 & 2028 (%)

9.3         Hospitals

9.3.1        Overview

9.3.2        Hospitals: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.4         Clinics

9.4.1        Overview

9.4.2        Clinics: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.5         Others

9.5.1        Overview

9.5.2        Others: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.        MEA Prostate Cancer Nuclear Medicine Diagnostics Market – By Country Analysis

10.1      MEA Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028

10.1.1     Overview

10.1.2     MEA: Prostate Cancer Nuclear Medicine Diagnostics Market, by Country, 2021 & 2028 (%)

10.1.2.1       UAE: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.2.1.1       Overview

10.1.2.1.2       UAE: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.2.1.3       UAE: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.2.1.4       UAE: Prostate Cancer Nuclear Medicine Diagnostics Market, PET Product, 2019–2028 (US$ ‘Million)

10.1.2.1.5       UAE: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ ‘Million)

10.1.2.2       Saudi Arabia: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.2.2.1       Overview

10.1.2.2.2       Saudi Arabia: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.2.2.3       Saudi Arabia: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.2.2.4       Saudi Arabia: Prostate Cancer Nuclear Medicine Diagnostics Market, PET Product, 2019–2028 (US$ ‘Million)

10.1.2.2.5       Saudi Arabia: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ ‘Million)

10.1.2.3       South Africa: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.2.3.1       Overview

10.1.2.3.2       South Africa: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.2.3.3       South Africa: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.2.3.4       South Africa: Prostate Cancer Nuclear Medicine Diagnostics Market, PET Product, 2019–2028 (US$ ‘Million)

10.1.2.3.5       South Africa: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ ‘Million)

10.1.2.4       Rest of MEA: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.2.4.1       Overview

10.1.2.4.2       Rest of MEA: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.2.4.3       Rest of MEA: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.2.4.4       Rest of MEA: Prostate Cancer Nuclear Medicine Diagnostics Market, PET Product, 2019–2028 (US$ ‘Million)

10.1.2.4.5       Rest of MEA: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ ‘Million)

11.        Prostate Cancer Nuclear Medicine Diagnostics Market–Industry Landscape

11.1      Overview

11.2      Growth Strategies in the Prostate Cancer Nuclear Medicine Diagnostics Market, 2021-2028

11.3      Inorganic Growth Strategies

11.3.1     Overview

11.4      Organic Growth Strategies

11.4.1     Overview

12.        Company Profiles

12.1      ImaginAb

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Curium

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      ABX advanced biochemical compounds GmbH

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Telix Pharmaceuticals Ltd.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Novartis AG

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Lantheus Medical Imaging, Inc.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             UAE: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 2.             UAE: Prostate Cancer Nuclear Medicine Diagnostics Market, PET Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 3.             UAE: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)

Table 4.             Saudi Arabia: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 5.             Saudi Arabia: Prostate Cancer Nuclear Medicine Diagnostics Market, PET Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 6.             Saudi Arabia: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)

Table 7.             South Africa: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 8.             South Africa: Prostate Cancer Nuclear Medicine Diagnostics Market, PET Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 9.             South Africa: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)

Table 10.          Rest of Middle East and Africa: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 11.          Rest of MEA: Prostate Cancer Nuclear Medicine Diagnostics Market, PET Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 12.          Rest of Middle East and Africa: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)

Table 13.          Recent Inorganic Growth Strategies in the Prostate Cancer Nuclear Medicine Diagnostics Market

Table 14.          Recent Organic Growth Strategies in the Prostate Cancer Nuclear Medicine Diagnostics Market

Table 15.          Glossary of Terms, Prostate Cancer Nuclear Medicine Diagnostics Market

LIST OF FIGURES

Figure 1.           MEA Prostate Cancer Nuclear Medicine Diagnostics Market Segmentation

Figure 2.           MEA Prostate Cancer Nuclear Medicine Diagnostics Market, By Country

Figure 3.           MEA Prostate Cancer Nuclear Medicine Diagnostics Market Overview

Figure 4.           PET Segment Held Largest Share of Type Segment in Prostate Cancer Nuclear Medicine Diagnostics Market

Figure 5.           MEA is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           MEA: PEST Analysis

Figure 7.           MEA Experts Opinion

Figure 8.           MEA Prostate Cancer Nuclear Medicine Diagnostics Market Impact Analysis of Drivers and Restraints

Figure 9.           MEA Prostate Cancer Nuclear Medicine Diagnostics Market– Revenue Forecast and Analysis – 2020 - 2028

Figure 10.        MEA Prostate Cancer Nuclear Medicine Diagnostics Market, by Type, 2022 & 2028 (%)

Figure 11.        MEA SPECT: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        MEA PET: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        MEA Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product, 2022 & 2028 (%)

Figure 14.        MEA F-18: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 15.        MEA C-11: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 16.        MEA GA 68 PSMA: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 17.        MEA Prostate Cancer Nuclear Medicine Diagnostics Market Share by End User - 2022 & 2028 (%)

Figure 18.        MEA Hospitals: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 19.        MEA Clinics: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 20.        MEA Others: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 21.        Middle East and Africa: Prostate Cancer Nuclear Medicine Diagnostics Market, by Key Country – Revenue (2022) (US$ ‘Million)

Figure 22.        MEA: Prostate Cancer Nuclear Medicine Diagnostics Market, by Country, 2022 & 2028 (%)

Figure 23.        UAE: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 24.        Saudi Arabia: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 25.        South Africa: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 26.        Rest of MEA: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 27.        Growth Strategies in the Prostate Cancer Nuclear Medicine Diagnostics Market, 2021-2028